China Resources Jiangzhong Pharmaceutical Co.,Ltd (SHA:600750)
China flag China · Delayed Price · Currency is CNY
26.35
+0.30 (1.15%)
Apr 8, 2026, 3:00 PM CST

SHA:600750 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
4,2074,4044,5273,8462,856
Other Revenue
12.8431.5126.2339.5817.88
4,2204,4354,5533,8852,874
Revenue Growth (YoY)
-4.87%-2.59%17.19%35.19%17.72%
Cost of Revenue
1,4581,6341,6481,3841,026
Gross Profit
2,7622,8012,9062,5011,848
Selling, General & Admin
1,5261,7241,8621,7131,196
Research & Development
152.79130.43141.4299.9787.82
Other Operating Expenses
47.3641.5855.3559.3152.48
Operating Expenses
1,7241,9042,0581,8741,336
Operating Income
1,037897.39847.35626.7511.29
Interest Expense
-1.81-1.71-6.98-4.38-3.46
Interest & Investment Income
75.7377.4868.793726.3
Other Non Operating Income (Expenses)
0.517.57-2.29-12.33-8.77
EBT Excluding Unusual Items
1,112990.74906.87646.99525.36
Gain (Loss) on Sale of Investments
0.59-11.46-40.0557.151.25
Gain (Loss) on Sale of Assets
0.611.841.22-0.130.9
Asset Writedown
-0.68-1.05-2.04--
Other Unusual Items
100.5245.5450.1249.3245.63
Pretax Income
1,2131,026916.12753.28623.14
Income Tax Expense
225.17165.11129.11106.8992.19
Earnings From Continuing Operations
987.55860.51787.01646.39530.95
Net Income to Company
987.55860.51787.01646.39530.95
Minority Interest in Earnings
-80.87-72.31-68.34-48.15-25.26
Net Income
906.69788.19718.67598.24505.69
Net Income to Common
906.69788.19718.67598.24505.69
Net Income Growth
15.03%9.67%20.13%18.30%6.74%
Shares Outstanding (Basic)
634631719630632
Shares Outstanding (Diluted)
634631719630632
Shares Change (YoY)
0.55%-12.26%14.12%-0.38%0.07%
EPS (Basic)
1.431.251.000.950.80
EPS (Diluted)
1.431.251.000.950.80
EPS Growth
14.40%25.00%5.26%18.75%6.67%
Free Cash Flow
690.29495.49828.31676.02728.55
Free Cash Flow Per Share
1.090.791.151.071.15
Dividend Per Share
1.3801.2001.3001.1500.650
Dividend Growth
15.00%-7.69%13.04%76.92%140.74%
Gross Margin
65.45%63.16%63.81%64.37%64.29%
Operating Margin
24.58%20.23%18.61%16.13%17.79%
Profit Margin
21.49%17.77%15.78%15.40%17.59%
Free Cash Flow Margin
16.36%11.17%18.19%17.40%25.35%
EBITDA
1,1841,033971.28746.78626.2
EBITDA Margin
28.06%23.28%21.33%19.22%21.79%
D&A For EBITDA
146.62135.29123.94120.08114.91
EBIT
1,037897.39847.35626.7511.29
EBIT Margin
24.58%20.23%18.61%16.13%17.79%
Effective Tax Rate
18.57%16.10%14.09%14.19%14.79%
Revenue as Reported
4,2204,4354,5533,8852,874
Advertising Expenses
385.39364.67404.92318.77321.22
Source: S&P Global Market Intelligence. Standard template. Financial Sources.